Morning Wire cover image

Morning Wire

Pill Politics: The Supreme Battle Over Mifepristone | Saturday Extra

Mar 23, 2024
10:28
Snipd AI
This podcast delves into the Supreme Court battle over mifepristone, with insights on the importance of doctor's visits, risks of unsupervised medication use, severe complications, and challenges in drug regulation. The attorney advocating for restrictions on mifepristone sheds light on these crucial topics.
Read more

Podcast summary created with Snipd AI

Quick takeaways

  • At-home abortions with Mifepristone are increasing, with FDA safeguards being questioned.
  • Supreme Court case focuses on regulating access to Mifepristone, highlighting risks of minimal medical oversight.

Deep dives

Increasing Popularity of At-Home Abortions

At-home abortions using medication have been on the rise, with six in ten abortions in 2023 being performed this way, up from 53 percent in 2020. The data from the Gutmacher Institute highlights the trend towards at-home abortions becoming the preferred method. The Supreme Court is set to address a case aiming to restrict access to abortion drug Mifepristone, which can currently be obtained through mail without medical supervision.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode